CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2011; 32(01): 49-54
DOI: 10.4103/0971-5851.81892

Extranodal testicular anaplastic versus plasmablastic plasma cell tumor: A rare case with diagnostic dilemma in a developing country

P. Jovita M Martin
Department of Oncology, Sri Ramachandra Medical College, Porur, Chennai, India
Anita Ramesh
Department of Oncology, Sri Ramachandra Medical College, Porur, Chennai, India
Simon Hercules
Department of Surgery, New Hope Medical Center, Kilpauk, India
T Dhanasekar
Department of Pulmonology and Internal Medicine, Sri Ramachandra Medical College and Hospital, Porur, Chennai, India
V S Mallikarjuna
Department of Pathology, Apollo Speciality, Teynampet, Chennai, Tamil Nadu, India
Lionel Rohit Mathew
Department of Pathology, Apollo Speciality, Teynampet, Chennai, Tamil Nadu, India
› Author Affiliations
Source of Support Nil.


Primary testicular plasmacytoma is rare, especially when occurring in the absence of a previous or concurrent diagnosis of multiple myeloma. An 84-year-old gentleman was admitted with complaints of swelling over the right side of scrotum for the past 2 months. Local examination revealed a 10×15 cm tense and tender swelling involving the right scrotum. Therefore, high orchidectomy with excision of hemiscrotum was done. The histopathology revealed testicular plasmacytoma, which was positive for CD 138.

Publication History

Article published online:
16 August 2021

© 2011. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

  • References

  • 1 Levin HS, Mostofi FK. Symptomatic plasmacytoma of the testis. Cancer 1970;25:1193-203.
  • 2 Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649-55.
  • 3 Kapadia SB, Desai U, Cheng VS. Extramedullary plasmacytoma of the head and neck: A clinicopathologic study of 20 cases. Medicine (Baltimore) 1982;61:317-29.
  • 4 Hayes DW, Bennett WA, Heck FJ. Extramedullary lesions in multiple myeloma; review of literature and pathologic studies. AMA Arch Pathol 1952;53:262-72.
  • 5 Anghel G, Petti N, Remotti D, Ruscio C, Blandino F, Majolino I. Testicular plasmacytoma: Report of a case and review of the literature. Am J Hematol 2002;71:98-104.
  • 6 Gowing NF. Malignant lymphoma of the testis. Br J Urol 1964;36:85-94.
  • 7 Alexiou C, Kau RJ, Dietzfelbinger H, Kremer M, Spiess JC, Schratzenstaller B, et al. Extramedullary plasmacytoma: Tumor occurrence and therapeutic concepts. Cancer 1999;85:2305-14.
  • 8 Liebisch P, Dohner H. Cytogenetics and molecular cytogenetics in multiple myeloma. Eur J Cancer 2006;42:1520-9.
  • 9 Laso FJ, Tabernero MD, Iglesias-Osma MC. Extramedullary plasmacytoma: A localized or systemic disease? Ann Intern Med 1998;128:156.
  • 10 Tsang RW, Gospodarowicz MK, Pintilie M, Bezjak A, Wells W, Hodgson DC, et al. Solitary plasmacytoma treated with radiotherapy: Impact of tumor size on outcome. Int J Radiat Oncol Biol Phys 2001;50:113-20.
  • 11 Colomo L, Loong F, Rives S, Pittaluga S, Martínez A, López-Guillermo A, et al. Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol 2004;28:736-47.
  • 12 Teruya-Feldstein J, Chiao E, Filippa DA, Lin O, Comenzo R, Coleman M, et al. CD20-negative large cell lymphoma with plasmablastic features: A clinically heterogenous spectrum in both HIV positive and negative patient. Ann Oncol 2004;15:1673-9.